Schorno Dean L 4

What Happened

• Dean L. Schorno, Chief Financial Officer of Rigel Pharmaceuticals (RIGL), disposed of 3,546 shares on Feb 10, 2026 as payment to cover tax or exercise obligations (transaction code F). The shares are reported at $34.62 each, for a total value of approximately $122,763.
• This was a share surrender/withholding to satisfy tax/exercise liabilities (not an open-market sale seeking cash proceeds).

Key Details

• Transaction date: 2026-02-10; filing date (Form 4): 2026-02-12.
• Price per share reported: $34.62; total value ~ $122,763.
• Transaction type/code: F — payment of exercise price or tax liability by delivering or withholding shares.
• Shares owned after transaction: not specified in the provided filing.
• Filing timeliness: filed two days after the transaction (appears timely, not flagged as late).

Context

• Code F typically means the insider surrendered shares to cover taxes or the exercise price related to option vesting; this is an administrative disposition and does not necessarily indicate a personal decision to liquidate holdings for investment reasons.
• For retail investors, tax-withholding dispositions are common after option exercises or restricted stock vesting and are different from voluntary open-market sales, which can be a stronger signal of insider sentiment.